---
category: news
title: "Panakeiaâ€™s PANProfiler AI Cancer Test Gains CE Mark, UKCA Approval"
excerpt: "London-based Panakeia has received CE mark certification for its PANProfiler artificial intelligence-based cancer image analysis system. The software analyzes digital images of breast tumor samples and predicts whether the cancer cells have estrogen or progesterone receptors,"
publishedDateTime: 2021-10-25T19:42:00Z
originalUrl: "https://www.fdanews.com/articles/205024-panakeias-panprofiler-ai-cancer-test-gains-ce-mark-ukca-approval"
webUrl: "https://www.fdanews.com/articles/205024-panakeias-panprofiler-ai-cancer-test-gains-ce-mark-ukca-approval"
type: article
quality: 17
heat: 17
published: false

provider:
  name: FDAnews
  domain: fdanews.com

topics:
  - AI

secured: "lUYUBtiHLSp2HCIrW5m1XOCrmwsEi4VTkq9bEckGSJwYdh8jvCnJA8FEVIvENw2bQVqDUwO83LNJhoEHDGS2FbT3duVw8ZZ7QNwQrIKw1dF720ys8BGus/JeQsRkVD2cCUtRhUGpk1AixscSod9UoAfbpXEYqG1ls3yNbJSQJr6C2WF29BpEc3fUC8HhXGYDQH4KkBq3AvFIT5J6GfMWgSnJkyr49/IjSHwLygP0hajnoMOAlcAHfsNsrmsZ+x/u+b2Ob6uyd7cmYf1JMmGR4nl4QThfDgok9VSIdAPIJC67XwPz6QjJzqlxZDbYkLR84AbbDqs4cnQaEm6JdSFNxNcPRqFRU51mePMWiYnJBbM=;B5s8pJwTYE3/hQIkL1sgBg=="
---

